524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹34
- High
- ₹38
- 52 Week Low
- ₹27
- 52 Week High
- ₹58
- Open Price₹36
- Previous Close₹36
- Volume21,993
Investment Returns
- Over 1 Month -14.62%
- Over 3 Month -15.21%
- Over 6 Month -9.16%
- Over 1 Year -39.49%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 77.2
- PEG Ratio
- 1.2
- Market Cap Cr
- 49
- P/B Ratio
- 1.8
- Average True Range
- 3.05
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.1
- RSI
- 39.53
- MFI
- 25.85
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹34.23
-1.8
(-5%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹37.10
- 50 Day
- ₹37.68
- 100 Day
- ₹38.50
- 200 Day
- ₹37.52
Resistance and Support
35.42
- R3 40.18
- R2 38.99
- R1 36.61
- S1 33.04
- S2 31.85
- S3 29.47
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results | |
| 2025-07-16 | Others | Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters. |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹34 As on 28 December, 2025 | 18:04
The Market Cap of Bacil Pharma is ₹49.1 Cr As on 28 December, 2025 | 18:04
The P/E ratio of Bacil Pharma is 77.2 As on 28 December, 2025 | 18:04
The PB ratio of Bacil Pharma is 1.8 As on 28 December, 2025 | 18:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.